Skip to content

TriSalus Life Sciences, Inc. TLSI Warrants and Rights Outstanding

Warrants and Rights Outstanding at other companies

Nuvation Bio logo
Nuvation BioNUVB
5.8M0.0%
Microbot Medical logo
Microbot MedicalMBOT
16.3M
KEE
Keel Infrastructure Corp. Common StockKEEL
2.2M
Unusual Machines logo
Unusual MachinesUMAC
0-100%
The Marygold Companies logo
The Marygold CompaniesMGLD
82.5K
KRAKacquisition
 logo
KRAKacquisition KRAQ
0

Other financials

Income statement

See full
Revenue$8.9M-2.9%
Gross profit$7.7M0.0%
Operating income-$8.4M-14.8%
Net income$1.5M+115%
EPS (diluted)$0.03+108%

Balance sheet

See full
Cash & equivalents$56.6M+324%
Total debt$33.1M+4.4%
Total equity$12.8M+137%
Total assets$71.0M+148%

Cash flow

See full
Operating cash flow-$6.5M-44.0%
CapEx$141.0K-81.3%
Free cash flow-$6.6M-26.0%

Valuation

See full
Market cap$279.45M+49.6%
Enterprise value$255.97M+33.6%
P/S6.2×+1.0×

Profitability

See full
Gross margin85.1%-0.5pp
Operating margin-62.4%-16.8pp
Net margin-60.9%-13.4pp
FCF margin-45.2%-16.8pp

Returns & leverage

See full
Return on equity253.3%
Debt / equity2.6×
Current ratio5.8×+3.6×

Where this comes from

Reported directly by TriSalus Life Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightOutstanding.

The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about TriSalus Life Sciences, Inc.'s warrants and rights outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TriSalus Life Sciences, Inc.'s warrants and rights outstanding?
TriSalus Life Sciences, Inc. (TLSI) reported warrants and rights outstanding of 7.4M in Q1 2026.
How has TriSalus Life Sciences, Inc.'s warrants and rights outstanding changed year-over-year?
TriSalus Life Sciences, Inc.'s warrants and rights outstanding decreased by 0.0% year-over-year, from 7.4M to 7.4M.
What is the long-term trend for TriSalus Life Sciences, Inc.'s warrants and rights outstanding?
Over 3 years (2022 to 2025), TriSalus Life Sciences, Inc.'s warrants and rights outstanding has grown at a 37.1% compound annual growth rate (CAGR), from 2.9M to 7.4M.